FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * MOORE A BRUCE JR   2. Issuer Name and Ticker or Trading Symbol HCA Healthcare, Inc. [HCA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Group President - Service Line (Last) (First) (Middle) ONE PARK PLAZA 3. Date of Earliest Transaction (Month/Day/Year) 01/31/2018 (Street) NASHVILLE, TN 37203 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 01/31/2018   M   27,030 A $ 5.9821 115,756 D   Common Stock 01/31/2018   M   40,545 A $ 6.4772 156,301 D   Common Stock 01/31/2018   M   13,515 A $ 10.9168 169,816 D   Common Stock 01/31/2018   M   13,515 A $ 15.9112 183,331 D   Common Stock 01/31/2018   S   66,845 D $ 101.0457 (1) 116,486 D   Common Stock               8,489 I By MAM Trust (Spouse, Trustee) Common Stock               12,435 I By MRM Trust (Spouse, Trustee) Common Stock               8,489 I By TCM Trust (Spouse, Trustee) Common Stock               109,392 I By 2016 GRAT (Spouse, Trustee) Common Stock               90,608 I By 2017 GRAT

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Non-Qualified Stock Option (right to buy)

$ 5.9821 (2)

01/31/2018

M

27,030

(3)

08/27/2019

Common Stock

27,030 (4)

$ 0

0

D

Non-Qualified Stock Option (right to buy)

$ 6.4772 (2)

01/31/2018

M

13,515

08/27/2011

08/27/2019

Common Stock

13,515 (4)

$ 0

0

D

Non-Qualified Stock Option (right to buy)

$ 6.4772 (2)

01/31/2018

M

27,030

(5)

08/27/2019

Common Stock

27,030 (4)

$ 0

0

D

Non-Qualified Stock Option (right to buy)

$ 10.9168 (2)

01/31/2018

M

13,515

08/27/2010

08/27/2019

Common Stock

13,515 (4)

$ 0

0

D

Non-Qualified Stock Option (right to buy)

$ 15.9112 (2)

01/31/2018

M

13,515

(6)

08/27/2019

Common Stock

13,515 (4)

$ 0

0

D

Stock Appreciation Right

$ 101.16

01/31/2018

A

32,020

01/31/2019(7)

01/31/2028

Common Stock

32,020

$ 0

32,020

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
MOORE A BRUCE JR ONE PARK PLAZA NASHVILLE, TN 37203			Group President - Service Line

Signatures

/s/ Natalie Harrison Cline, Attorney-in-Fact		02/02/2018
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.20, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(2)	Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
(3)	The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013.
(4)	Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
(5)	The option vested at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets.
(6)	The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets.
(7)	The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.